Adenosine A2B receptor mediates an increase on VEGF-A production in rat kidney glomeruli

Biochemical and Biophysical Research Communications

Volumn 366, Issue 1, 2008, Pages 180-185

  Valladares, D ^a   Quezada, C ^a   Montecinos, P ^a   Concha II, ^a   Yanez A J ^a   Sobrevia, L ^b   Martín, R San ^a  

^a UNIVERSIDAD AUSTRAL DE CHILE   (Chile)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Adenosine receptor; Glomerulus; High d glucose; VEGF A

Indexed keywords

ADENOSINE; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A2B RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; ADENOSINE RECEPTOR STIMULATING AGENT; GLUCOSE; VASCULOTROPIN A;

ANIMAL TISSUE; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; GLOMERULUS; MALE; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN LOCALIZATION; RAT;

ANIMALS; CELLS, CULTURED; KIDNEY GLOMERULUS; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ADENOSINE A2B; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

RATTUS;

EID: 37449020797     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.11.113     Document Type: Article

References (37)

1. Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocr. Rev. 25 (2004) 581-611
2. Tufro A., Norwood V.F., Carey R.M., and Gomez R.A. Vascular endothelial growth factor induces nephrogenesis and vasculogenesis. J. Am. Soc. Nephrol. 10 (1999) 2125-2134
3. Schrijvers B.F., Flyvbjerg A., and De Vriese A.S. The role of vascular endothelial growth factor in renal pathophysiology. Kidney Int. 65 (2004) 2003-2017
4. Eremina V., Baelde H.J., and Quaggin S.E. Role of the VEGF-A signaling pathway in the glomerulus: evidence for crosstalk between components of the glomerular filtration barrier. Nephron Physiol. 106 (2007) 32-37
5. Kitamoto Y., Tokunaga H., Miyamoto K., and Tomita K. VEGF is an essential molecule for glomerular structuring. Nephrol. Dial. Transplant. 17 (2002) 25-27
6. Foster R., Hole R., Anderson K., Satchell S., Coward R., Mathieson P., Gillatt D., Saleem M., Bates D., and Harper S. Functional evidence that vascular endothelial growth factor may act as an autocrine factor on human podocytes. Am. J. Physiol. Renal Physiol. 284 (2003) 1263-1273
7. Sugimoto H., Hamano Y., Charytan D., Cosgrove D., Kieran M., Sudhakar A., and Kalluri R. Neutralization of circulating vascular endothelial growth factor by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria. J. Biol. Chem. 278 (2003) 12605-12608
8. Eremina V., Cui S., Gerber H., Ferrara N., Haigh J., Nagy A., Ema M., Rossant J., Jothy S., Miner J.H., and Quaggin S. Vascular endothelial growth factor a signaling in the podocyte-endothelial compartment is required for mesangial cell migration and survival. J. Am. Soc. Nephrol. 17 (2006) 724-735
9. Liu E., Morimoto M., Kitajima S., Koike T., Yu Y., Shiiki H., Nagata M., Watanabe T., and Fan J. Increased expression of vascular endothelial growth factor in kidney leads to progressive impairment of glomerular functions. J. Am. Soc. Nephrol. 18 (2007) 2094-2104
10. Shweiki D., Itin A., Soffer D., and Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature (London) 359 (1992) 843-845
11. Wakelin S., Marson L., Howie S., Garden J., Lamb J., and Forsythe J. The role of vascular endothelial growth factor in the kidney in health and disease. Nephron Physiol. 98 (2004) 73-79
12. Hoshi S., Shu Y., Yoshida F., Inagaki T., Sonoda J., Watanabe T., Nomoto K., and Nagata M. Podocyte injury promotes progressive nephropathy in Zucker diabetic fatty rats. Lab. Invest. 82 (2002) 25-35
13. Iglesias-De la Cruz M., Ziyadeh F., Isono M., Kouahou M., Han D., Kalluri R., Mundel P., and Chen S. Effects of high glucose and TGF-beta1 on the expression of collagen IV and vascular endothelial growth factor in mouse podocytes. Kidney Int. 62 (2002) 901-913
14. Vallon V., Mühlbauer B., and Osswald H. Adenosine and kidney function. Physiol. Rev. 86 (2006) 901-940
15. Foidart J., Dechenne C., Mahieu P., Creutz C., and De Mey J. Tissue culture of normal rat glomeruli. Isolation and morphological characterization of two homogeneous cell lines. Invest. Cell Pathol. 2 (1979) 15-26
16. Fredholm B., Ijzerman A., Jacobson K., Klotz K., and Linden J. International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol. Rev. 53 (2001) 527-552
17. Casanello P., Torres A., Sanhueza F., Gonzalez M., Farias M., Gallardo V., Pastor-Anglada M., San Martin R., and Sobrevia L. Equilibrative nucleoside transporter 1 expression is downregulated by hypoxia in human umbilical vein endothelium. Circ. Res. 97 (2005) 16-24
18. San Martín R., Cáceres P., Azócar R., Alvarez M., Molina A., Vera M., and Krauskopf M. Seasonal environmental changes modulate the prolactin receptor expression in an eurythermal fish. J. Cell. Biochem. 92 (2004) 42-52
19. Vasquez G., Sanhueza F., Vasquez R., Gonzalez M., San Martin R., Casanello P., and Sobrevia L. Role of adenosine transport in gestational diabetes-induced l-arginine transport and nitric oxide synthesis in human umbilical vein endothelium. J. Physiol. 560 (2004) 111-122
20. 1 receptor mRNA in microdissected rat nephron segments. Hypertension 26 (1995) 1181-1185
21. Vitzthum H., Weiss B., Bachleitner W., Krämer B.K., and Kurtz A. Gene expression of adenosine receptors along the nephron. Kidney Int. 65 (2004) 1180-1190
22. Pawelczyk T., Grden M., Rzepko R., Sakowicz M., and Szutowicz A. Region-specific alterations of adenosine receptors expression level in kidney of diabetic rat. Am. J. Pathol. 167 (2005) 315-325
23. Cha D., Kim N., Yoon J., Jo S., Cho W., Kim H., and Won N. Role of vascular endothelial growth factor in diabetic nephropathy. Kidney Int. 77 (2000) 104-112
24. Cha D., Kang Y., Han S., Jee Y., Han K., Han J., Kim Y., and Kim N. Vascular endothelial growth factor is increased during early stage of diabetic nephropathy in type II diabetic rats. J. Endocrinol. 183 (2004) 183-194
25. Munoz G., San Martin R., Farias M., Cea L., Vecchiola A., Casanello P., and Sobrevia L. Insulin restores glucose inhibition of adenosine transport by increasing the expression and activity of the equilibrative nucleoside transporter 2 in human umbilical vein endothelium. J. Cell. Physiol. 209 (2006) 826-835
26. Sakowicz M., Szutowicz A., and Pawelczyk T. Differential effect of insulin and elevated glucose level on adenosine transport in rat B lymphocytes. Int. Immunol. 17 (2005) 145-154
27. Huang D.Y., Vallon V., Zimmermann H., Koszalka P., Schrader J., and Osswald H. Ecto-5′-nucleotidase (cd73)-dependent and -independent generation of adenosine participates in the mediation of tubuloglomerular feedback in vivo. Am. J. Physiol. Renal Physiol. 291 (2006) F282-F288
28. 1 receptor antagonist KW-3902 prevents hypoxia-induced renal vasoconstriction. J. Pharmacol. Exp. Ther. 291 (1999) 988-993
29. Kang Y., Park Y., Kim B., Han S., Jee Y., Han K., Lee M., Song H., Cha D., Kang S., and Han D. Angiotensin II stimulates the synthesis of vascular endothelial growth factor through the p38 mitogen activated protein kinase pathway in cultured mouse podocytes. J. Mol. Endocrinol. 36 (2006) 377-388
30. Chen S., Lee J., Iglesias-De la Cruz M., Wang A., Izquierdo-Lahuerta A., Gandhi N., Danesh F., Wolf G., and Ziyadeh F. Angiotensin II stimulates alpha3(IV) collagen production in mouse podocytes via TGF-beta and VEGF signalling: implications for diabetic glomerulopathy. Nephrol. Dial. Transplant. 20 (2005) 1320-1328
31. Yoo T., Li J., Kim J., Jung D., Kwak S., Ryu D., Choi H., Kim J., Kim H., Han S., Lee J., Han D., and Kang S. Activation of the renin-angiotensin system within podocytes in diabetes. Kidney Int. 71 (2007) 1019-1027
32. Grant M.B., Tarnuzzer R.W., Caballero S., Ozeck M.J., Davis M.I., Spoerri P.E., Feoktistov I., Biaggioni I., Shryock J.C., and Belardinelli L. Adenosine receptor activation induces vascular endothelial growth factor in human retinal endothelial cells. Circ. Res. 85 (1999) 699-706
33. 2B receptors in angiogenic factor regulation. Circ. Res. 90 (2002) 531-538
34. 2B angiogenic phenotype. Hypertension 44 (2004) 649-654
35. 2B receptor in hypoxia. FASEB J. 20 (2006) 2242-2250
36. Makino H., Miyamoto Y., Sawai K., Mori K., Mukoyama M., Nakao K., Yoshimasa Y., and Suga S. Altered gene expression related to glomerulogenesis and podocyte structure in early diabetic nephropathy of db/db mice and its restoration by pioglitazone. Diabetes 55 (2006) 2747-2756
37. Eremina V., Sood M., Haigh J., Nagy A., Lajoie G., Ferrara N., Gerber H.P., Kikkawa Y., Miner J.H., and Quaggin S.E. Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J. Clin. Invest. 111 (2003) 707-716